WebBenefits The intuitively designed ID NOW™ instrument can have a positive impact in any healthcare setting. Easy to use with only minimal training requirements Large visual touchscreen displays results, eliminating transcription errors and the need for printing Small footprint saves you bench space and can be used in any healthcare setting WebFeb 27, 2015 · For influenza B, Alere ™ iNAT detected 75% of those positive by RT-PCR, versus 33·3% and 25·0% for Sofia ® and BinaxNOW ®, respectively. The specificity of Alere ™ iNAT was 100% for influenza A and 99% for influenza B. Conclusions. Alere ™ i Influenza A&B is a promising new rapid influenza diagnostic assay with potential point …
Alere™ Influenza A & B Test - Trans Continental Medical Products
WebAlere™ i Influenza A & B 24 Test Kit 425-024 Alere™ i Influenza A & B Control Swab Kit 425-080 Product Specifications Sample Types Time to Result <15 minutes CPT® Code 87502 Accurate Performance Alere™ i vs. PCR7 PPA: Positive Percentage Agreement NPA: Negative Percentage Agreement A new level of confidence in test sensitivitya,b … WebThe AlereTM Influenza A & B Test provides a simple, rapid method as an aid in the differential diagnosis of influenza A & B using nasal swab specimens. This easy-to … roboguard bad reviews
Influenza A & B Card Product Instructions - inofficelab.com
WebThe Alere™ Influenza A & B Test is an in-vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasal swab specimens collected from symptomatic patients. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. WebPositive and Negative Percent Agreements of the Alere™ Influenza A & B Test with Viral Culture for Influenza Type B Number of samples PPA 95% CI NPA 95% CI 612 82.5 % (99/120) 74. %, 88.3% 98.4 (484/492) 96.8%, 99.2% A study was conducted to evaluate the performance of the Alere™ Influenza A & B Test with weakly reactive samples when … WebApr 28, 2014 · Posted by admin on April 28th, 2014. Alere i™ Influenza A & B delivers molecular flu results in less than 15 minutes on our unique Alere i platform; making it significantly faster than other molecular methods and more accurate than conventional rapid tests. Rapid diagnostic tests with increased sensitivity are essential for the reliable ... robogrip wrench